Abstract
This study validated that health education effectively reduced the frequency and severity of acute attacks in AIP patients while enhancing their mental health status and quality of life. Internet-based health education emerges as a practical and productive strategy for AIP patients.
Introduction
Acute Intermittent Porphyria (AIP) is a rare genetic metabolic disorder characterized by life-threatening "attacks" involving severe abdominal pain and neurological symptoms. These episodes are often triggered by external factors such as specific medications, infections, or emotional stress. Due to the rarity of the disease, patients frequently lack the specialized knowledge required for effective management, leading to a cycle of unpredictable attacks and high levels of anxiety and depression. In regions where advanced orphan drugs like Givosiran are not readily available, self-management strategies—such as increasing glucose intake at the first sign of symptoms—are critical. This study investigates the efficacy of a structured, internet-based multidisciplinary education program in breaking this cycle.
Methods
The study utilized a pre-post comparison design involving a cohort of 52 patients diagnosed with AIP at the Second Hospital of Hebei Medical University between 2021 and 2023. The cohort was predominantly female (96.15%), with a mean age of approximately 27 years.
The intervention was led by a Multi-disciplinary Treatment (MDT) team and consisted of three primary components delivered over 12 months:
- Online Lectures: Bi-monthly sessions covering disease etiology, triggers, and prevention strategies.
- Psychological Counseling: Bi-monthly sessions focused on emotional regulation and stress reduction to mitigate psychological triggers.
- Continuous Support: Real-time interaction via WeChat for personalized guidance and prompt clinical advice.
Clinical progress was evaluated using the DASS-21 (Depression, Anxiety, and Stress), PANAS (Positive and Negative Affect), and SF-36 (Quality of Life) scales, alongside tracking the frequency and severity of acute episodes.
Results
The 12-month internet-based program yielded significant clinical and psychological improvements:
- Reduction in Attack Frequency: The proportion of patients experiencing frequent attacks (≥4 times per year) decreased from 55.8% to 23.1%.
- Decreased Severity: The percentage of patients experiencing three or more severe attacks annually dropped from 17.3% to 0%.
- Improved Mental Health: There were marked improvements in Positive Affect (PANAS) and significant reductions in anxiety and stress scores (DASS-21).
- Enhanced Quality of Life: The Physical Component Summary (PCS) of the SF-36 improved significantly from 241.21 to 289.18 ($p < 0.001$).
These results suggest that education serves as a potent clinical intervention. By empowering patients to identify prodromal symptoms and avoid triggers, the biological frequency of attacks can be reduced. Furthermore, addressing the stress-attack feedback loop through psychological counseling directly impacts physical health outcomes.
Discussion and Conclusion
The study highlights the value of digital continuity of care. Unlike traditional one-off educational interventions, the ongoing support provided by online meetings and social media platforms creates a "safety net" that improves treatment adherence and patient self-efficacy. This is particularly vital in contexts where high-cost medications are unavailable, as it enables patients to utilize simple, effective interventions like oral hypertonic glucose at the appropriate time.
While the findings are promising, the study is limited by its single-center design, relatively small sample size ($n=52$), and lack of a control group. Future research should involve multi-center, prospective randomized controlled trials to further validate these outcomes and incorporate objective physiological markers alongside self-reported data. In conclusion, internet-based health education is a scalable and effective strategy for managing rare diseases like AIP, bridging the gap in specialized clinical access.
Summary updated